These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 15319442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.
    Tan CM, Nickols HH, Limbird LE.
    J Biol Chem; 2003 Sep 12; 278(37):35678-86. PubMed ID: 12824183
    [Abstract] [Full Text] [Related]

  • 3. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2005 Aug 12; 289(2):F265-72. PubMed ID: 16006591
    [Abstract] [Full Text] [Related]

  • 4. A serine cluster prevents recycling of the V2 vasopressin receptor.
    Innamorati G, Sadeghi HM, Tran NT, Birnbaumer M.
    Proc Natl Acad Sci U S A; 1998 Mar 03; 95(5):2222-6. PubMed ID: 9482866
    [Abstract] [Full Text] [Related]

  • 5. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
    Estall JL, Koehler JA, Yusta B, Drucker DJ.
    J Biol Chem; 2005 Jun 10; 280(23):22124-34. PubMed ID: 15817468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.
    Yi X, Bouley R, Lin HY, Bechoua S, Sun TX, Del Re E, Shioda T, Raychowdhury MK, Lu HA, Abou-Samra AB, Brown D, Ausiello DA.
    Am J Physiol Renal Physiol; 2007 May 10; 292(5):F1303-13. PubMed ID: 17287200
    [Abstract] [Full Text] [Related]

  • 10. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
    Juul KV, Bichet DG, Nielsen S, Nørgaard JP.
    Am J Physiol Renal Physiol; 2014 May 01; 306(9):F931-40. PubMed ID: 24598801
    [Abstract] [Full Text] [Related]

  • 11. VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
    Rihakova L, Quiniou C, Hamdan FF, Kaul R, Brault S, Hou X, Lahaie I, Sapieha P, Hamel D, Shao Z, Gobeil F, Hardy P, Joyal JS, Nedev H, Duhamel F, Beauregard K, Heveker N, Saragovi HU, Guillon G, Bouvier M, Lubell WD, Chemtob S.
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct 01; 297(4):R1009-18. PubMed ID: 19641130
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. O-Glycosylation of the V2 vasopressin receptor.
    Sadeghi H, Birnbaumer M.
    Glycobiology; 1999 Jul 01; 9(7):731-7. PubMed ID: 10362843
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.
    Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan 01; 357(1):63-9. PubMed ID: 9459574
    [Abstract] [Full Text] [Related]

  • 16. Molecular aspects of vasopressin receptor function.
    Schöneberg T, Kostenis E, Liu J, Gudermann T, Wess J.
    Adv Exp Med Biol; 1998 Jan 01; 449():347-58. PubMed ID: 10026824
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells.
    Robben JH, Knoers NV, Deen PM.
    Mol Biol Cell; 2004 Dec 01; 15(12):5693-9. PubMed ID: 15469988
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ, Giełdoń A, Slusarz R, Ciarkowski J.
    J Pept Sci; 2006 Mar 01; 12(3):180-9. PubMed ID: 16114100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.